A Novel, Interpretable Machine Learning Model Predicts Furosemide Dosing After Congenital Cardiac Surgery - Report - MDSpire

A Novel, Interpretable Machine Learning Model Predicts Furosemide Dosing After Congenital Cardiac Surgery

  • By

  • Daniel E. Ehrmann

  • Matthew W. Hodgman

  • Emily M. Wittrup

  • John R. Charpie

  • Gabe E. Owens

  • Ranjit Aiyagari

  • Kayvan Najarian

  • May 7, 2026

  • 0 min

Share

Clinical Report: Predicting Furosemide Dosage After Congenital Heart Surgery

Overview

This report presents the development of a novel, interpretable machine learning model, the TGFNN-R, aimed at predicting furosemide dosage for managing fluid overload in neonates post-congenital heart surgery. The model leverages fuzzy logic to enhance clinical decision-making and reduce variability in diuretic titration practices.

Background

Fluid overload following congenital cardiac surgery is a significant concern, linked to increased morbidity and mortality. Current diuretic titration methods vary widely among clinicians and institutions, potentially leading to inadequate treatment. The introduction of a machine learning model designed to assist in diuretic dosing could standardize care and improve patient outcomes.

Data Highlights

No specific numerical data was provided in the source material.

Key Findings

  • The TGFNN-R model utilizes fuzzy logic to interpret clinical data more closely aligned with clinician decision-making.
  • Neonates undergoing congenital heart surgery are particularly susceptible to postoperative fluid overload, necessitating precise diuretic management.
  • Current practices for diuretic titration are inconsistent, contributing to risks of under- or over-diuresis.
  • Machine learning models like TGFNN-R can potentially enhance clinical decision support systems in pediatric cardiac care.
  • Early diuretic administration is associated with improved clinical outcomes in neonates post-surgery.

Clinical Implications

The implementation of the TGFNN-R model could standardize diuretic dosing practices, thereby reducing variability and improving patient safety. Clinicians should consider integrating such machine learning tools into their decision-making processes to enhance fluid management in postoperative care.

Conclusion

The TGFNN-R model represents a promising advancement in the use of artificial intelligence for clinical decision support in pediatric cardiac surgery. Its interpretability may facilitate adoption and improve outcomes in managing fluid overload.

Related Resources & Content

  1. Pediatric Cardiology, 2025 -- Urine Output Following Furosemide Infusion in Infants Post-Cardiopulmonary Bypass as an Indicator of Acute Kidney Injury Risk
  2. npj Digital Medicine, 2025 -- Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome prediction
  3. npj Digital Medicine, 2026 -- An Interpretable Machine Learning Approach for Predicting Postoperative Risks and Supporting Surgical Decisions in Cranioplasty
  4. The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)
  5. Early Diuretic Administration After Neonatal Cardiac Surgery and Association with Clinical Outcomes: A Report from NEPHRON, 2025
  6. An Innovative Predictive Approach for Ureteroscopy and Laser Lithotripsy Utilizing Machine Learning and Explainable AI: Insights from the FLEXOR Global Database
  7. The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)
  8. Early Diuretic Administration After Neonatal Cardiac Surgery and Association with Clinical Outcomes: A Report from NEPHRON - Nicole Stegmeier, Jeffrey Alten, Santiago Borasino, Michael (Adam) Carlisle, Abhishek Chakraborty, Katja M Gist, Garrett Reichle, David Selewski, Huaiyu Zang, Jill Zender, Rebecca Bertrandt, 2025
  9. label

Original Source(s)

Related Content